Earlier this week, Bayer announced positive topline results from its Phase III OCEANIC-STROKE trial, showing that asundexian ...

If you have ever wondered whether Bayer is really a bargain or just another risky pharma play, you are not alone. Let's dig ...

Bayer (BAYZF) stock is in focus as the FDA grants accelerated approval for the company's tumor drug Hyrnuo in non-squamous ...

In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...

Shares of Regeneron Pharmaceuticals REGN have gained 21.5% year to date compared with the industry’s growth of 10.2%. The ...

Litigation costs seen impacting 2025 reported earnings CEO has said aims to resolve most glyphosate cases by 2026 Bayer has cut 13,500 jobs to speed up decision making FRANKFURT, Nov 12 (Reuters) - ...

The phase 2 ChonDRAgon study compared ozekibart to placebo in patients with metastatic or unresectable conventional chondrosarcoma who been diagnosed with radiographic progression.

Germany's Bayer said Wednesday it had set aside more money to deal with long-running legal woes related to weedkillers, even as investors cheered better-than-expected quarterly earnings. The maker of ...

It will be a battle between the top two teams in the Champions League when Bayern Munich visits Arsenal on Wednesday. Arsenal ...

Dr. Sapphire Clinic is internationally regarded as the most renowned surgeon for hair transplants in Turkey. He speaks ...

Bayer issued a "surprisingly positive" report for its blood thinner over the weekend, prodding Bristol Myers Squibb stock ...

The top 5 best hair transplant clinics in Turkey for 2025. Compare results, techniques, prices, and patient reviews to choose the right clinic for safe and natural-looking hair restoration.